Tech Network Grenada
SEE OTHER BRANDS

Get your fresh news on science and technology in Grenada

Tech Network Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Network Grenada.

Press releases published on June 4, 2025

From One-Size-Fits-All to Custom Built Models: Personal AI Charts an Alternative Path – ”No LLM” Required

From One-Size-Fits-All to Custom Built Models: Personal AI Charts an Alternative Path – ”No LLM” Required

SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- Personal AI today made a public declaration: “No LLM.” While Personal Language Models (PLMs) have quietly emerged as an alternative to general-purpose AI, Personal AI is the first to fully lean in, framing …

Noma Security Named to Exclusive “Rising in Cyber 2025” List as Leader in Enterprise AI Security

Noma Security Named to Exclusive “Rising in Cyber 2025” List as Leader in Enterprise AI Security

TEL AVIV, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- Noma Security, the unified AI security and governance platform, today announced its inclusion in Rising in Cyber 2025, an independent list launched by Notable Capital to spotlight the 30 most-promising …

Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma

Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma

Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma Paris, France, June 4th, 2025. Oncovita, a biotechnology company developing innovative virus-based immunotherapies for …

Copyleaks Named No. 2 on TIME’s List of World’s Top EdTech Rising Stars of 2025

Copyleaks Named No. 2 on TIME’s List of World’s Top EdTech Rising Stars of 2025

NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Copyleaks, a pioneering AI content analysis and governance platform used by enterprises, educational institutions, and individual users across the globe, has been named No. 2 on the second edition of the World’s …

Progress Software Sets New Standard for Developer Productivity with Groundbreaking AI Coding Assistants in Latest Telerik and Kendo UI Release

Progress Software Sets New Standard for Developer Productivity with Groundbreaking AI Coding Assistants in Latest Telerik and Kendo UI Release

BURLINGTON, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Progress Software (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure software, today announced the Q2 2025 release of Progress® Telerik® and Progress® Kendo UI®, the …

Axonius Named a Top Cybersecurity Startup

Axonius Named a Top Cybersecurity Startup

Company selected by CISOs and leading investors; Notable Capital’s Rising in Cyber 2025 honors 30 startups shaping the future of security NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Axonius, the global leader in cyber asset management that delivers …

KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative

KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative

Lakewood, CO, June 04, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative KRTL Holding Group Inc. (OTC: KRTL) announces a significant advancement in its …

60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format

60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format

New 8-count bottles now available through major retail pharmacies ARAKODA® is the only weekly prophylactic therapy to provide protection against the blood and liver stages of malaria WASHINGTON, June 04, 2025 (GLOBE NEWSWIRE) --  60 Degrees Pharmaceuticals …

Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

PALM BEACH, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The Retinal and Fundis Camera market has shown growth in the recent years and is expected to continue for years to come. Fundus cameras are sophisticated instruments …

Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107)

Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107)

Annamycin delivering better performance 7th line than would be expected even in 2nd line for monotherapy Responders (Stable Disease or Partial Response) after 2 cycles of Annamycin showed improvement in OS and Progression Free Survival (“PFS”) Clinical …

Telos Corporation Awarded $14M Contract with the Defense Information Systems Agency

Telos Corporation Awarded $14M Contract with the Defense Information Systems Agency

ASHBURN, Va., June 04, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it was awarded the Defense …

Aligned Data Centers Debuts Advanced Cooling Lab to Further Accelerate Cooling Technology Innovation for Next-Gen GPUs

Aligned Data Centers Debuts Advanced Cooling Lab to Further Accelerate Cooling Technology Innovation for Next-Gen GPUs

DALLAS , June 04, 2025 (GLOBE NEWSWIRE) -- Aligned Data Centers, a leading technology infrastructure company offering innovative, sustainable and adaptive Scale Data Centers and Build-to-Scale solutions for global hyperscale, AI / HPC, and enterprise …

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

PITTSBURGH, June 04, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced that it …

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

Glucotrack to present on next-generation continuous blood glucose monitoring technology in Innovation Hub Poster presentation to highlight insights on safety and performance data from direct blood glucose measurement technology RUTHERFORD, N.J., June 04, …

Veea and StarGroup Join Forces to Transform Mexico’s Digital Divide with Smart Connectivity and Entertainment Solutions

Veea and StarGroup Join Forces to Transform Mexico’s Digital Divide with Smart Connectivity and Entertainment Solutions

NEW YORK and MEXICO CITY, June 04, 2025 (GLOBE NEWSWIRE) -- Veea Inc. (NASDAQ: VEEA), a global innovator in edge computing and AI-driven platforms, and StarGroup, one of Mexico’s most dynamic and visionary telecommunications and entertainment providers, …

ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance

ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance

LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a specialty pharmaceutical company, today announced that it remains fully operational and is actively working to complete its overdue annual and quarterly financial …

Biodexa Announces Recruitment of First Patient  in Phase 2 Study of Tolimidone in Type 1 Diabetes

Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes

June 4, 2025 Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of …

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to capture commercial potential in the $15 billion animal health market Evaluation of AZD5658 expands Conduit’s …

ClarityCut AI Unveils New Creative Engine for Branded Video Production

ClarityCut AI Unveils New Creative Engine for Branded Video Production

SEATTLE, June 04, 2025 (GLOBE NEWSWIRE) -- CLEANZONE HVAC LLC has introduced the next evolution of video creation with the latest update to its AI-powered platform, ClarityCut AI. Designed for content creators, educators, and digital marketers, ClarityCut …

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

MIRAMAR, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions